This page contains a Flash digital edition of a book.
First-line and Salvage Treatment Strategies in Patients with Advanced-stage Follicular Lymphoma 1. 2. 3.


Young RC, Longo DL, Glatstein E, et al., Semin Hematol, 1988;25:11–16.


Brice P, Bastion Y, Lepage E, et al., J Clin Oncol, 1997;15:1110–17.


Ardeshna KM, Smith P, Norton A, et al., Lancet, 2003;362:516–22.


4. Horning SJ, Rosenberg SA, N Engl J Med, 1984;311:1471–5. 5.


Lister TA, Cullen MH, Beard ME, et al., Br Med J, 1978;1:533–7.


6. 7.


Dana BW, Dahlberg S, Nathwani BN, et al., J Clin Oncol, 1993;11:644–51.


Nickenig C, Dreyling M, Hoster E, et al., Cancer, 2006;107: 1014–22.


8. Horning SJ, Ann Oncol, 2000;11:23–7. 9. Hainsworth JD, Semin Oncol, 2003;30:9–15. 10. Ghielmini M, Schmitz SF, Blood, 2004;103:4416–23. 11. Hiddemann W, Kneba M, Dreyling M, et al., Blood, 2005;106:3725–32.


12. Marcus R, Imrie K, Belch A, et al., Blood, 2005;105: 1417–23.


13. Herold M, Haas A, Srock S, et al., J Clin Oncol, 2007;25: 1986–92.


14. Salles G, Mounier N, de Guibert S, et al., Blood, 2008;112: 4824–31.


15. Buske C, Hoster E, Dreyling M, et al., Blood, 2008;112:2599. 16. Salles GA, Seymour JF, Feugier P, et al., J Clin Oncol, 2010;28:15S.


17. Rohatiner AZ, Gregory WM, Peterson B, et al., J Clin Oncol, 2005;23:2215–23.


18. Davis TA, Kaminski MS, Leonard JP, et al., Clin Cancer Res, 2004;10:7792–8.


19. Kaminski MS, Tuck M, Estes J, et al., N Engl J Med, 2005;352:441–9.


20. Leonard JP, Coleman M, Kostakoglu L, et al., J Clin Oncol, 2005;23:5696–704.


21. Shipley DL, Greco FA, Spigel DR, et al., J Clin Oncol, 2005;23: 16–6577.


22. DeMonaco NA, Wu M, Osborn J, et al., Blood, 2005;106:2449.


23. Press OW, Unger JM, Braziel RM, et al., J Clin Oncol, 2006;24:4143–9.


24. Jacobs SA, Swerdlow SH, Kant J, et al., Clin Cancer Res, 2008;14(21):7088–94.


25. Morschhauser F, Radford J, Van Hoof A, et al., J Clin Oncol, 2008;26:5156–64.


26. Lenz G, Dreyling M, Schiegnitz E, et al., Blood, 2004;104: 2667–74.


27. Lenz G, Dreyling M, Schiegnitz E, et al., J Clin Oncol, 2004;22:4926–33.


28. Sebban C, Mounier N, Brousse N, et al., Blood, 2006;108: 2540–44.


29. Ladetto M, De Marco F, Benedetti F, et al., Blood, 2008;111:4004–13.


30. Gyan E, Foussard C, Bertrand P, et al., Blood, 2009;113: 995–1001.


31. Brugger W, Hirsch J, Grunebach F, et al., Ann Oncol, 2004;15:1691–8.


32. Rummel MJ, Niederle N, Maschmeyer G, et al., Blood, 2009;114:405.


33. Johnson PW, Rohatiner AZ, Whelan JS, et al., J Clin Oncol, 1995;13:140–47.


34. van Oers MH, Klasa R, Marcus RE, et al., Blood, 2006;108: 3295–301.


35. Forstpointner R, Unterhalt M, Dreyling M, et al., Blood, 2006;108:4003–8.


36. Witzig TE, Flinn IW, Gordon LI, et al., J Clin Oncol, 2002;20: 3262–9.


37. Witzig TE, Gordon LI, Cabanillas F, et al., J Clin Oncol, 2002;20:2453–63.


38. Witzig TE, White CA, Gordon LI, et al., J Clin Oncol, 2003;21: 1263–70.


39. Gordon LI, Witzig T, Molina A, et al., Clin Lymphoma, 2004;5: 98–101.


40. Wiseman GA, Gordon LI, Multani PS, et al., Blood, 2002;99: 4336–42.


41. Witzig TE, Molina A, Gordon LI, et al., Cancer, 2007;109: 1804–10.


42. Rohatiner AZ, Johnson PW, Price CG, et al., J Clin Oncol, 1994;12:1177–84.


43. Bastion Y, Brice P, Haioun C, et al., Blood, 1995;86: 3257–62.


44. Bierman PJ, Vose JM, Anderson JR, et al., J Clin Oncol, 1997;15:445–50.


45. Freedman AS, Neuberg D, Mauch P, et al., Blood, 1999;94:3325–33.


46. Apostolidis J, Gupta RK, Grenzelias D, et al., J Clin Oncol, 2000;18:527–36.


47. Brice P, Simon D, Bouabdallah R, et al., Ann Oncol, 2000;11: 1585–90.


48. Schouten HC, Qian W, Kvaloy S, et al., J Clin Oncol, 2003;21: 3918–27.


49. Sebban C, Brice P, Delarue R, et al., J Clin Oncol, 2008;26: 3614–20.


50. Weigert O, Uysal A, Metzner B, et al., Blood, 2008;112:2189. 51. Hoerr AL, Gao F, Hidalgo J, et al., J Clin Oncol, 2004;22: 4561–6.


52. Kang TY, Rybicki LA, Bolwell BJ, et al., Bone Marrow Transplant, 2007;40:973–8.


53. Leonard BM, Hetu F, Busque L, et al., Blood, 1998;91: 331–9.


54. Verdonck LF, Leuk Lymphoma, 1999;34:129–36. 55. Heinzelmann F, Ottinger H, Muller CH, et al., Strahlenther Onkol, 2006;182:222–30.


56. Schneider RA, Schultze J, Jensen JM, et al., Strahlenther Onkol, 2007;183:545–51.


57. Gerstein J, Meyer A, Sykora KW, et al., Strahlenther Onkol, 2009;185:751–5.


58. Ricardi U, Filippi AR, Biasin E, et al., Strahlenther Onkol, 2009;185:17–20.


59. Pommier P, Sunyach MP, Pasteuris C, et al., Strahlenther Onkol, 2009;185:13–6.


60. Cosset JM, Socie G, Girinsky T, et al., Semin Radiat Oncol, 1995;5:301–15.


61. van Besien KW, Khouri IF, Giralt SA, et al., J Clin Oncol, 1995;13:1096–1102.


62. van Besien K, Sobocinski KA, Rowlings PA, et al., Blood, 1998;92:1832–6.


63. van Besien K, Loberiza FR Jr., Bajorunaite R, et al., Blood, 2003;102:3521–9.


64. Mandigers CM, Raemaekers JM, Schattenberg AV, et al., Br J Haematol, 1998;100:198–206.


65. Forrest DL, Thompson K, Nevill TJ, et al., Bone Marrow Transplant, 2002;29:973–8.


66. Yakoub-Agha I, Fawaz A, Folliot O, et al., Bone Marrow Transplant, 2002;30:229–34.


67. Kiss TL, Panzarella T, Messner HA, et al., Bone Marrow Transplant, 2003;31:73–8.


68. Hosing C, Saliba RM, McLaughlin P, et al., Ann Oncol, 2003;14:737–44.


69. Peniket AJ, Ruiz de Elvira MC, Taghipour G, et al., Bone Marrow Transplant, 2003;31:667–78.


70. Toze CL, Barnett MJ, Connors JM, et al., Br J Haematol, 2004;127:311–21.


71. Hari P, Carreras J, Zhang MJ, et al., Biol Blood Marrow Transplant, 2008;14:236–45.


72. Ingram W, Devereux S, Das-Gupta EP, et al., Br J Haematol, 2008;141:235–43.


73. Kuruvilla J, Pond G, Tsang R, et al., Biol Blood Marrow Transplant, 2008;14:775–82.


74. Avivi I, Montoto S, Canals C, et al., Br J Haematol, 2009;147: 719–28.


75. Maloney DG, Hematology Am Soc Hematol Educ Program, 2007;226–32.


76. Ratanatharathorn V, Uberti J, Karanes C, et al., Blood, 1994;84:1050–55.


77. van Besien KW, de Lima M, Giralt SA, et al., Bone Marrow Transplant, 1997;19:977–82.


78. Slavin S, Nagler A, Naparstek E, et al., Blood, 1998;91: 756–63.


79. Storb RF, Champlin R, Riddell SR, et al., Hematology Am Soc Hematol Educ Program, 2001;375–91.


80. Khouri IF, Saliba RM, Giralt SA, et al., Blood, 2001;98: 3595–9.


81. Robinson SP, Goldstone AH, Mackinnon S, et al., Blood, 2002;100:4310–16.


82. Tanimoto TE, Kusumi E, Hamaki T, et al., Bone Marrow Transplant, 2003;32:131–7.


83. Faulkner RD, Craddock C, Byrne JL, et al., Blood, 2004;103: 428–34.


84. Morris E, Thomson K, Craddock C, et al., Blood, 2004;104: 3865–71.


85. Maris MB, Sandmaier BM, Storer B, et al., Blood, 2005;106:1130.


86. Kusumi E, Kami M, Kanda Y, et al., Bone Marrow Transplant, 2005;36:205–13.


87. Khouri IF, Saliba RM, Hosing CM, et al., Blood, 2005; 106:48.


88. Vigouroux S, Michallet M, Porcher R, et al., Haematologica, 2007;92:627–34.


89. Corradini P, Dodero A, Farina L, et al., Blood, 2008;112: 3303.


90. Rezvani AR, Storer B, Maris M, et al., J Clin Oncol, 2008;26: 211–17.


91. Casper J, Knauf W, Kiefer T, et al., Blood, 2004;103: 725–31.


92. Beelen DW, Trenschel R, Casper J, et al., Bone Marrow Transplant, 2005;35:233–41.


93. Ott OJ, Rodel C, Gramatzki M, et al., Strahlenther Onkol, 2003;179:694–701.


94. Sakata K, Satoh M, Someya M, et al., Strahlenther Onkol, 2005;181:385–91.


95. Perez A, Grabenbauer GG, Sprung CN, et al., Strahlenther Onkol, 2007;183:99–106.


96. Aviles A, Delgado S, Fernandez R, et al., Eur J Haematol, 2002;68:144–9.


97. Ganem G, Lambin P, Socie G, et al., Hematol Oncol, 1994;12:1–8.


98. Sawyer EJ, Timothy AR, Radiother Oncol, 1997;42:49–51. 99. Johannsson J, Specht L, Mejer J, et al., Int J Radiat Oncol Biol Phys, 2002;54:1466–70.


100.Girinsky T, Guillot-Vals D, Koscielny S, et al., Int J Radiat Oncol Biol Phys, 2001;51:148–55.


101.Haas RL, Poortmans P, de Jong D, et al., J Clin Oncol, 2003;21:2474–80.


102.Ng M, Wirth A, Ryan G, et al., Value of low-dose 2 x 2 Gy palliative radiotherapy in advanced low-grade non-Hodgkin’s lymphoma, Australas Radiol, 2006;50:222–7.


103.Haas RL, de Jong D, Valdes Olmos RA, et al., Int J Radiat Oncol Biol Phys, 2004;59:782–7.


104.Bischof M, Karagiozidis M, Krempien R, et al., Strahlenther Onkol, 2007;183:17–22.


105.Gerstein J, Kofahl-Krause D, Fruhauf J, et al., Strahlenther Onkol, 2008;184:484–7.


106.Haas RL, Girinsky T, Ann Hematol, 2003;82:458–62.


EUROPEAN ONCOLOGY


63


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92
Produced with Yudu - www.yudu.com